Nu Skin Enterprises (NYSE:NUS) Releases FY 2025 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 1.250-1.350 for the period, compared to the consensus EPS estimate of 1.260. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion. Nu Skin Enterprises also updated its Q4 2025 guidance to 0.250-0.350 EPS.

Nu Skin Enterprises Stock Performance

Nu Skin Enterprises stock traded down $1.71 during trading hours on Friday, hitting $9.13. The company had a trading volume of 1,258,515 shares, compared to its average volume of 625,844. The firm has a 50-day moving average of $11.36 and a 200 day moving average of $9.45. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.01 and a quick ratio of 1.38. The firm has a market cap of $451.67 million, a PE ratio of 4.54 and a beta of 0.97. Nu Skin Enterprises has a one year low of $5.32 and a one year high of $14.62.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.30 by $0.04. The business had revenue of $364.21 million for the quarter, compared to the consensus estimate of $374.20 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.250-1.350 EPS. Q4 2025 guidance at 0.250-0.350 EPS. On average, sell-side analysts expect that Nu Skin Enterprises will post 1.05 earnings per share for the current year.

Nu Skin Enterprises Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 10th. Shareholders of record on Friday, November 28th will be given a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Friday, November 28th. Nu Skin Enterprises’s payout ratio is 11.01%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on NUS shares. Wall Street Zen upgraded Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a research report on Sunday, October 12th. Zacks Research raised shares of Nu Skin Enterprises to a “hold” rating in a research report on Tuesday, August 12th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Nu Skin Enterprises in a research note on Wednesday, October 8th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $7.00.

Insider Activity at Nu Skin Enterprises

In related news, Director Daniel W. Campbell sold 23,391 shares of the company’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $12.10, for a total transaction of $283,031.10. Following the completion of the transaction, the director owned 53,375 shares in the company, valued at $645,837.50. This represents a 30.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Chayce David Clark sold 20,000 shares of the business’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $11.97, for a total transaction of $239,400.00. Following the sale, the executive vice president owned 233,140 shares in the company, valued at approximately $2,790,685.80. This trade represents a 7.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 58,926 shares of company stock worth $711,364 in the last 90 days. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Nu Skin Enterprises

Several institutional investors have recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC grew its position in Nu Skin Enterprises by 107.4% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company’s stock worth $40,000 after purchasing an additional 2,614 shares during the period. Amundi grew its stake in Nu Skin Enterprises by 18.8% in the 1st quarter. Amundi now owns 18,564 shares of the company’s stock valued at $127,000 after acquiring an additional 2,941 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of Nu Skin Enterprises during the 1st quarter worth about $162,000. Russell Investments Group Ltd. raised its holdings in shares of Nu Skin Enterprises by 18.5% during the second quarter. Russell Investments Group Ltd. now owns 20,405 shares of the company’s stock valued at $163,000 after acquiring an additional 3,179 shares during the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new position in Nu Skin Enterprises in the 2nd quarter valued at $174,000. Hedge funds and other institutional investors own 82.84% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.